The Chief Scientific Officer (CSO) must ensure that the scientific research and product development of the business is best-in-class.
Often at the forefront of their disciplines, many CSO’s are world-leading scientists in their own fields. The role can be broad, which requires CCO to work closely with clients to identify the more important assessment criteria for the appointment, where issues under consideration often include balancing responsibilities from discovery research, to pre-clinical, and clinical development. The depth, complexity and mix of the product pipeline can also determine aspects of selection.
The ability to lead people, influence, and align the strategic components of the role is a crucial element to the CSO skillset, as the post-holder will often be leading the largest team in a life sciences organisation. The need for a CSO to blend scientific expertise with strategic business issues, manage budgets, and engage, align, and motivate scientific talent of their teams is also important, as well as being the biggest advocate for the company by communicating the impact the business can make on patients lives.
Compass Carter Osborne was engaged by Hengrui Therapeutics to source a Vice President – Head of European Research Centre, Biological Drug Discovery to be responsible for building a preclinical discovery science lab in Switzerland
This was a critical succession planning hire for AKW with their longstanding and successful CEO retiring, against a backdrop of the current investor owners approaching a proposed exit.
As a result of our previous relationship with the current Chief Executive Officer, CCO was invited to a competitive pitch where the team were able to demonstrate the key attributes PreventX were looking for in a search partner.
Uniquely differentiated by operating in a group of companies dedicated to investor backed healthcare and life sciences sectors, trusting CCO with a search means you get more than just the advisory services offering.
The knowledge-sharing, grass-roots insights, and talent identification through our contingent sister brands provides a broad picture of the sector landscape where insights of this level are rarely matched by other providers. Access to the group’s premium contingent brands presents the opportunity for a single point of contact responsible for all aspects of an organisation’s hiring and retention needs.
Learn more about how the group can add value through our sister brands.
As the dedicated executive search and advisory services offering in the Compass house of brands, learn all about how our additional brands makes us your natural choice for all recruitment needs.
Insight
Transitioning from executive to non-executive
Our latest round table, addressing the transition from Executive to Non-Executive has been extremely well received by our networks and we would like to extend our gratitude to all attendees for what was a very engaging and informative discussion. You don’t want to miss it.
Insight CCO win the Executive Search Firm of the Year
Judges feedback included, “No question that Compass Carter Osborne is now a leading name in the sector, recognised for providing outstanding C-suite and SMT appointments who add value to the businesses they lead, and can demonstrate exceptional EBITDA returns on exit.”
